期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Non-alcoholic fatty liver disease and hepatocellular carcinoma:Clinical challenges of an intriguing link 被引量:2
1
作者 Lampros Chrysavgis ilias giannakodimos +1 位作者 Panagiota Diamantopoulou Evangelos Cholongitas 《World Journal of Gastroenterology》 SCIE CAS 2022年第3期310-331,共22页
Non-alcoholic fatty liver disease(NAFLD)has emerged as the most common liver disorder worldwide mainly attributed to the epidemic spread of obesity and type 2 diabetes mellitus.Although it is considered a benign disea... Non-alcoholic fatty liver disease(NAFLD)has emerged as the most common liver disorder worldwide mainly attributed to the epidemic spread of obesity and type 2 diabetes mellitus.Although it is considered a benign disease,NAFLD can progress to non-alcoholic steatohepatitis,liver cirrhosis and hepatocellular carcinoma(HCC).Most data regarding the epidemiology of NAFLD-related HCC are derived from cohort and population studies and show that its incidence is increasing as well as it is likely to emerge as the leading indication for liver transplantation,especially in the Western World.Although cirrhosis constitutes the main risk factor for HCC development,in patients with NAFLD,HCC can arise in the absence of cirrhosis,indicating specific carcinogenic molecular pathways.Since NAFLD as an underlying liver disease for HCC is often underdiagnosed due to lack of sufficient surveillance in this population,NAFLDHCC patients are at advanced HCC stage at the time of diagnosis making the management of those patients clinically challenging and affecting their prognostic outcomes.In this current review,we summarize the latest literature on the epidemiology,other than liver cirrhosis-pathogenesis,risk factors and prognosis of NAFLD-HCC patients.Finally,we emphasize the prevention of the development of NAFLD-associated HCC and we provide some insight into the open questions and issues regarding the appropriate surveillance policies for those patients. 展开更多
关键词 Non-alcoholic fatty liver disease Hepatocellular carcinoma EPIDEMIOLOGY Risk factors SURVEILLANCE Risk stratification
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部